alzheimersdisease
In a recent study published in the journal Alzheimer’s & Dementia, researchers have discovered that the connectivity between the locus coeruleus and the medial temporal lobe can be an early indicator of Alzheimer’s disease-related brain atrophy and cognitive decline. They found that lower connectivity between these brain regions during a novelty task was associated with faster atrophy in regions typically affected by Alzheimer’s disease. The motivation behind the new study stemmed from the need to understand the early mechanisms of Alzheimer’s disease, which is characterized by the accumulatio...
PsyPost (CA)
In a recent study published in the journal Alzheimer’s & Dementia, researchers have discovered that the connectivity between the locus coeruleus and the medial temporal lobe can be an early indicator of Alzheimer’s disease-related brain atrophy and cognitive decline. They found that lower connectivity between these brain regions during a novelty task was associated with faster atrophy in regions typically affected by Alzheimer’s disease. The motivation behind the new study stemmed from the need to understand the early mechanisms of Alzheimer’s disease, which is characterized by the accumulatio...
PsyPost
In a recent study published in the journal Alzheimer’s & Dementia, researchers have discovered that the connectivity between the locus coeruleus and the medial temporal lobe can be an early indicator of Alzheimer’s disease-related brain atrophy and cognitive decline. They found that lower connectivity between these brain regions during a novelty task was associated with faster atrophy in regions typically affected by Alzheimer’s disease. The motivation behind the new study stemmed from the need to understand the early mechanisms of Alzheimer’s disease, which is characterized by the accumulatio...
PsyPost (UK)
A new study sheds light the potential mechanism linking a diet high in saturated fats to Alzheimer’s disease. Researchers have identified specific changes in small RNA molecules, known as microRNAs, that act as markers and regulators of the disease, shedding light on how dietary habits can influence the onset of neurodegenerative conditions. The findings were published in the journal Nutrients. “The results of this study are a step forward in our understanding of this disease and may explain the relationship between obesity, type 2 diabetes and the onset of Alzheimer’s. The findings also offer...
PsyPost
A new study sheds light the potential mechanism linking a diet high in saturated fats to Alzheimer’s disease. Researchers have identified specific changes in small RNA molecules, known as microRNAs, that act as markers and regulators of the disease, shedding light on how dietary habits can influence the onset of neurodegenerative conditions. The findings were published in the journal Nutrients. “The results of this study are a step forward in our understanding of this disease and may explain the relationship between obesity, type 2 diabetes and the onset of Alzheimer’s. The findings also offer...
PsyPost (CA)
A new study sheds light the potential mechanism linking a diet high in saturated fats to Alzheimer’s disease. Researchers have identified specific changes in small RNA molecules, known as microRNAs, that act as markers and regulators of the disease, shedding light on how dietary habits can influence the onset of neurodegenerative conditions. The findings were published in the journal Nutrients. “The results of this study are a step forward in our understanding of this disease and may explain the relationship between obesity, type 2 diabetes and the onset of Alzheimer’s. The findings also offer...
PsyPost (UK)
Recent scientific advancements have shown that a lesser-known compound from the cannabis plant, cannabinol (CBN), may hold promise for treating neurological disorders such as Alzheimer’s and Parkinson’s disease. Researchers at the Salk Institute discovered that not only does CBN protect brain cells from age-related damage, but its chemically modified versions could be even more effective. These findings, detailed in the journal Redox Biology, suggest a new frontier in the treatment of traumatic brain injuries and other neurodegenerative diseases. With the prevalence of neurological disorders r...
PsyPost (CA)
Recent scientific advancements have shown that a lesser-known compound from the cannabis plant, cannabinol (CBN), may hold promise for treating neurological disorders such as Alzheimer’s and Parkinson’s disease. Researchers at the Salk Institute discovered that not only does CBN protect brain cells from age-related damage, but its chemically modified versions could be even more effective. These findings, detailed in the journal Redox Biology, suggest a new frontier in the treatment of traumatic brain injuries and other neurodegenerative diseases. With the prevalence of neurological disorders r...
PsyPost (UK)
In the beautifully restored main hall of the Gorton Monastery in Manchester, a man in a wheelchair starts singing ‘Danny Boy’. The man has dementia and is part of a weekly group that gives people living with the debilitating illness support through musical workshops. The man’s voice is beautiful. Timid at first, the supportive atmosphere brings him out of his shell until his deep tones echo across the monastery. The workshop is part of Music in Mind, a programme that’s been run by the Manchester Camerata in Gorton for 12 years, and is about to be rolled out for every borough in the Greater Man...
Euronews (English)
Researchers have discovered that individuals who live to be 100 years old and remain cognitively healthy possess genetic variations that may protect against Alzheimer’s disease. These “protective alleles” are significantly more prevalent among centenarians compared to Alzheimer’s patients and even middle-aged individuals without the disease. This finding could pave the way for new approaches in preventing and treating Alzheimer’s, particularly by focusing on enhancing these protective genetic mechanisms. The new findings have been published in the journal Alzheimer’s & Dementia. Alzheimer’s di...
PsyPost
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら